MedPath

The effect of helicobacter pylori infection eradication on thrombocytopenia in patients with Liver failure.

Not Applicable
Conditions
Thrombocytopenia in cirrhotic patients.
Secondary thrombocytopenia
Registration Number
IRCT2013020112333N1
Lead Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
23
Inclusion Criteria

Patients with thrombocytopenia due to cirrhosis of the liver;
platelet count was less than 85,000 per micro liter; The immunoglubin anti- Helicobacter pylori antibodies were positive.
Exclusion criteria at the beginning: History of previous treatment for Helicobacter pylori infection eradication; treatment with proton pump inhibitors or antibiotics in the past four weeks; History of allergy drugs for eradicate of Helicobacter pylori infection.
Exclusion criteria during the study: allergy to drugs; Helicobacter pylori infection are not eradicated after treatment.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thrombocytopenia. Timepoint: Before and 4 weeks after the end of treatment. Method of measurement: Venous blood samples.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath